Pharmacogenomics and therapy for hepatitis C virus infection
Pharmacogenomic research has been active in the area of hepatitis C virus infection. Both viral and host polymorphisms are discussed in this review to describe how the genotype information helps predict response to conventional peginterferon alfa and ribavirin therapy as well as more recently recommended direct-acting antivirals, simeprevir and sofosbuvir. by M. Kawaguchi-Suzuki and Dr […]